Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Acknowledgements to Reviewers:
Volume: 15 Issue: 2
Export Options
About this article
Cite this article as:
Acknowledgements to Reviewers:, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2015; 15 (2) . https://dx.doi.org/10.2174/187152221502151013172046
DOI https://dx.doi.org/10.2174/187152221502151013172046 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
20
Related Articles
-
Investigating Physical, Psychological and Social Well-being of Older Persons in Jordan
Current Aging Science Lipid Composition of Cell Membranes and Its Relevance in Type 2 Diabetes Mellitus
Current Diabetes Reviews Parathyroid Hormone and Heart Failure: Novel Biomarker Strategy
Endocrine, Metabolic & Immune Disorders - Drug Targets Development, Optimization & Evaluation of Porous Chitosan Scaffold Formulation of Gliclazide for the Treatment of Type-2 Diabetes Mellitus
Drug Delivery Letters Repositioning the Old Fungicide Ciclopirox for New Medical Uses
Current Pharmaceutical Design Transition Metals for Conjugation of Polyunsaturated Acids and their Esters
Current Organic Chemistry Physicochemical Properties that Determine Cellular Transport of Nanocarriers In Vitro and In Vivo
Current Organic Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Medicinal Diets: From Molecules to Nutrients to Foods: Basic and Clinical Implications
Current Medicinal Chemistry Patent Selections
Recent Patents on Biomarkers BELFAST Centenarians: A Case of Optimal Cardiovascular Risk?
Current Pharmaceutical Design Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Stability of Synthetic Exendin-4 in Human Plasma In Vitro
Protein & Peptide Letters Oxidative Stress Drivers and Modulators in Obesity and Cardiovascular Disease: From Biomarkers to Therapeutic Approach
Current Medicinal Chemistry Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Current Medicinal Chemistry The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery
Current Topics in Medicinal Chemistry Metabolic Effects of Resveratrol in Mammals - a Link Between Improved Insulin Action and Aging
Current Aging Science TNF-α/Cycloheximide-Induced Oxidative Stress and Apoptosis in Murine Intestinal Epithelial MODE-K Cells
Current Pharmaceutical Design